Yatharth Hospital And Trauma Care Services Limited · NSE:YATHARTH
Yatharth Hospital And Trauma Care Services — Q3 FY26 Earnings Presentation
25 slides from Yatharth Hospital And Trauma Care Services's earnings presentation, Feb 5, 2026
Slide 1: Stock exchange cover letter for investor presentation
YH/SE/82/2025-26 February 05, 2026 The Listing Department Dept. of Listing Operations National Stock Exchange of India Limited BSE Limited, Exchange Plaza, 5th Floor, Plot No. C/1 Phiroze Jeejeebhoy Towers, G Block, Bandra-Kurla Complex, Bandra (E) Dalal Street, Mumbai – 400 051, India Mumbai - 4000
Slide 2: Q3 & 9M FY26 Earnings Presentation
Q3 & 9M FY26 Earnings Presentation February 5, 2026
Slide 3: Disclaimer
Disclaimer Certain matters discussed in this presentation may contain statements regarding the company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements does not guarantee future performance and are subject
Slide 4: Q3 & 9M FY26 Highlights
Q3 & 9M FY26 Highlights
Slide 5: Financial Snapshot for Q3 FY26
Financial Snapshot for Q3 FY26 Revenue EBITDA PAT EBITDA Margin Rs. 3,205 mn Rs. 742 mn Rs. 431 mn 23.2% +46% YoY +35% YoY +41% YoY Occupancy3 ARPOB Bed Capacity2 ALOS 67% Rs. 33,744 2,550+ beds 4.32 +11% YoY +10% YoY Adjusted for initial ramp up losses of New Delhi and Faridabad Sec-20, Group’s Adj
Slide 6: Growth in Action, with ramp up of Delhi and Faridabad Hospital
Growth in Action, with ramp up of Delhi and Faridabad Hospital Sec-20, Faridabad Model Town, New Delhi Commenced Commenced Sep-25 July-25 Bed Capacity Bed Capacity 400 Beds 300 Beds ❖ Acquisition of Sec-20 Faridabad hospital coupled with the earlier acquisition ❖ Catering to a large catchment of res
Slide 7: Successful Integration of Agra Hospital w.e.f. February 2026
Successful Integration of Agra Hospital w.e.f. February 2026 Well Established Multi-Speciality Hospital Noida Built across ~1,65,000 sq. ft. 14 L Bed Capacity 250 Beds 7L 1L 100% stake acquired at Rs. 260 Cr 9L 3L Integrated w.e.f. Feb 1, 2026 25 L To contribute meaningfully to both Revenue and EBIT
Slide 8: Strengthening Governance: Inspiring Trust for Our Stakeholders
Strengthening Governance: Inspiring Trust for Our Stakeholders Appointment of MSKA & Associates as statutory auditors 127% (a member firm of BDO International) Shareholder Return since listing Appointment of Mr. Ramesh Krishnan as Independent Director, a seasoned healthcare leader with 30+ yrs of ex
Slide 9: Financial Performance: Strongest-ever Quarter
Financial Performance: Strongest-ever Quarter Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% +46% +32% 3,000.00 2,9 2,9 94.00 88.00 28% 2,9 2,9 82.00 76 70 .0 2,958.00 .0 0 0 2,9 2,9 64.00 2,9 46.00 52.00 2,9 2,9 40.00 25.2% 2,9 2,9 34.00 2,928.00 2,9 2,9 2,9 22.00 16 .0 10 .0 00 2,8 04.00 2,8 2,8 98.00 9
Slide 10: Operational Performance: Improvement across Clinical Parameters
Operational Performance: Improvement across Clinical Parameters Bed Capacity & Occupancy (%) ARPOB (Rs.) & ALOS (days) 66% 50 49 000 900 4.7 50 000 5.5 49 49600800 700 4.69 4.4 49 49 900 5.48 9 49 4.68 49800 49 700 600 5.478 5.46 5.45 7 6 49 49 49 500 400 30 0 4.67 49 49 500 400 5.44 5.434 5 49 20 4
Slide 11: Diversifying Revenue across Hospitals
Diversifying Revenue across Hospitals 3 Hospitals in FY21 5 Hospitals in Q3 FY25 8* Hospitals in Q3 FY26 4% 5% 8% 7% 5% 30% Journey 30% 37% 35% 9% 20% Q3FY25 Q3FY26 FY21 Rs 3,205 mn Rs 2,287 mn Rs 2,192mn 18% 35% 30% 27% Noida Extension Greater Noida Noida Greater Faridabad Jhansi-Orchha Faridabad N
Slide 12: Expanding High Value Specialities across Hospitals
Expanding High Value Specialities across Hospitals Diverse mix of specialities at all hospitals 9M FY2026 20% 12% 10% 10% 9% 8% 7% 6% 5% 4% 3% 5% 9M FY2025 19% 11% 11% 10% 10% FY2021 56% Internal Medicine Neurosciences Nephrology & Urology Oncology Cardiology Orthopaedics, Spine & Rheumatology Pulmo
Slide 13: Profit & Loss Summary
Profit & Loss Summary Change Change Change Particulars (Rs mn) Q3FY26 Q3FY25 Q2FY26 9MFY26 9MFY25 YoY QoQ YoY Revenue from Operations 3,205 2,192 46% 2,794 15% 8,577 6,487 32% Medical Consumables & Pharmacy 625 421 48% 564 11% 1,724 1,320 31% Employee Expenses 635 426 49% 538 18% 1,655 1,187 39% Oth
Slide 14: At a Glance
lll Nyy YATHARTH \\()) Sine Ry Nn ATT TT
Slide 15: Leading Group of Super Speciality Hospitals in North India
Leading Group of Super Speciality Hospitals in North India 8 12 81% One-stop destination for patient needs providing Centres of comprehensive quaternary healthcare services Hospitals* Beds in Metros* Excellence 2019 Noida Extension 2025 450 beds Model Town, Delhi 300 beds 2,550+ Rs. 32,757 66% 2013
Slide 16: Our Growth Journey
Our Growth Journey Incorporation Commencement of Established the 450 Listing on NSE & Acquired hospital in of the 250 bedded hospital in bedded hospital in Noida BSE Agra, adding 250 company Noida Extension beds 2008 2010 2013 2018 2019 2022 2023 2024 2025 Acquired three hospitals – Established our
Slide 17: Backed by Marquee Investors, Focused on Shareholder Value Growth
Backed by Marquee Investors, Focused on Shareholder Value Growth Stock Data Key Investors 900 Kotak Mahindra Mutual Fund Jupiter India 127% Bandhan Mutual Fund Marval Capital Returns 700 since listing Motilal Oswal Mutual Fund Blackrock Groww Mutual Fund State Street Corp 31-Dec-25, 500 681.55 Canar
Slide 18: One of the Fastest Expanding Hospital Networks
One of the Fastest Expanding Hospital Networks Jhansi – Orchha Greater Noida 2022 Acquisition 2010 Incorporated 305 Beds; 76 ICU Beds 400 Beds; 112 ICU Beds (expandable to 600 beds) Greater Faridabad 2024 Acquisition 200 Beds; 72 ICU Beds Noida New Delhi 2013 Incorporated 2025 Commencement 250 Beds;
Slide 19: Clinical Excellence Backed by Cutting-Edge Infrastructure
Clinical Excellence Backed by Cutting-Edge Infrastructure Complex Presence in No. of Procedures DaVinci Robotic Systems LINAC Machine Joint Replacement Robots Procedures Hospitals performed till date Organ Noida Ext. & 230+ Transplants Gr. Noida All Hospitals Robotic Surgeries (excl. Noida & 950+ Jh
Slide 20: Strategically Positioned to Capture Medical Value Travel Opportunities
Strategically Positioned to Capture Medical Value Travel Opportunities Our Proximity to Jewar Airport to Spur Medical Value Travel Market Development & Brand Building Noida Extension ❖ Cardiac partnership in Ethiopia with Children’s Heart Fund and Black Lion Hospital; IVF CME and patient screening c
Slide 21: Core Strategies Driving Growth with Clinical Excellence
Core Strategies Driving Growth with Clinical Excellence Capacity Addition Track record of successful greenfield and brownfield expansion, with an announced capacity of ~3,000 beds Optimising Existing Infrastructure Enhancing occupancy across our hospitals Strengthening Clinical Infrastructure Invest
Slide 22: Annexures
” ® i =) >< o c c <q
Slide 23: Proven Record of Consistent Financial Performance
Proven Record of Consistent Financial Performance Revenue (Rs mn) EBITDA (Rs mn) & EBITDA% 3000 2994 2988 2982 2976 2970 2964 2958 2952 2946 2940 2934 29.3% 27.6% 25.7% 26.8% 25.0% 25.2% 23.7% 30% 28% 26% 24% 22% 20% 18% 16% 14% 11% 9% 7% FY21-25 2928 2922 5% 3% 2916 2910 1% -1% 2904 2898 -3% -5% 28
Slide 24: Consistent Performance across Operational Parameters
Consistent Performance across Operational Parameters Bed Capacity & Occupancy (%) 80 % ARPOB (Rs.) & ALOS (days) 3000 66% 61% 61% 70% 5.0 5.2 4.8 4.3 4.3 4.4 4.2 2500 54% 50% 60 % 3400 0 5 33200 32400 45% 31600 3080 0 42% 3000 0 29200 2000 50 % 2840 0 276 00 2680 0 2600 0 25200 0 2440 0 23600 22800
Slide 25: Thank You
Thank You Yatharth Hospital & Trauma Care Services Ltd Investor Relations Contact Mr. Ashutosh Kumar Jha, Group Chief – Strategy, M&A and IR investor.relations@yatharthhospitals.com CIN: L85110DL2008PLC174706 www.yatharthhospitals.com
Yatharth Hospital & Trauma Care Services — Q3 FY26 Earnings Presentation on 6ix